## ## ## ||||| |---|---|---|---| |CONTENTS|||Page| |Legal and administrative||information|| |Trustees'
report|||2 —19| |Independent
Auditor's||report|20-22| |Consolidated
statement||offinancial activities|23| |Charity and Group balance sheets|||24| |Consolidated
statement||ofcash flows|25| |Notes to the financial|statements||26-43| ## |REGISTERED NAME OF CHARITY|StWilfrid's Hospice (Eastbourne)|StWilfrid's Hospice (Eastbourne)| |---|---|---| |CHARITY NUMBER|283686|| |COMPANY NUMBER|01594410|| |PRINCIPAL OFFICE/REGISTERED OFFICE|1 Broadwater Way|| ||Eastbourne|| ||East Sussex|| ||BN22 9PZ|| |PRESIDENT|HM The Queen|| |PATRONS|The Duke ofDevonshire|| ||Mr David Dimbleby|| ||Dr Joan Hester|| |TRUSTEES|Mr S O' Leary (Chair)|| ||Mr D Adams|| ||Dr M Barnes|| ||Mrs JButler|| ||Ms BHobson (appointed|13September 2022)| ||Mr D Holdsworth
(appointed
13September 2022)|| ||Ms FMacIntyre|| ||Mr GMeyer|| ||Mrs M Richardson|| ||Mr DTurner|| |CHIEF EXECUTIVE|Mr CTwomey (appointed|1 January 2023)| ||Mr D Scott-Ralphs
(retired 31December 2022)|| |LEADERSHIP TEAM|Dr D Barclay (Medical Director)
Ms A Dechamps
(Patient 4 Family Support Director)|| ||Mr D Mackenzie
(Finance and ITDirector)|| ||Mrs P Russell (Development
Director)|| ||Mr C Twomey (Clinical Services Director) (until 31|| ||December 2022)|| ||Mrs RBacon (Associate Director for Clinical Services)|| ||Mrs G Chandler (Associate Director for People Services)|| ||Mrs LFree (Associate Medical Director)|| ||Mrs TSchrikker (Associate Director for Quality|| ||Improvement)|| |AUDITORS|Haysmacintyre
LLP|| ||10Queen Street Place|| ||London|| ||EC4R 1AG|| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||||2022/23|2021/22|Increase/decrease|Variance| |---|---|---|---|---|---|---| ||||E,k|Kk|Kk|| |Legacies|||3,848|2,894|954|33| |Donations|and|Gifts|1,805|1,780|25|1| |Lottery|||352|362|(10)|(3)| |Trading|||1,260|1,135|125|11| ## ## ## ## ## ## ## |Funding sources|Funding sources||| |---|---|---|---| |Our funding
comes from:|||| |||2022/23|2021/22| |Legacies||40%|32%| |Gifts and|Donations|18%|20%| |Statutory|Funding|23%|30%| |Trading||13%|13%| |Lottery||4%|4%| |Investments/other||2%|1%| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |Risk identified|Risk identified||Actions taken to mitigate the risk| |---|---|---|---| |Uncertainty|ofincome|and impact on cashflow.|Income
generation
strategy
focuses
on| ||||diversification
of
funding
streams.| ||||Establishment
oflegacy equalisation
reserve and| ||||increase
to 9 months
of free reserves
target.| ||||Rolling 3 year financial
and scenario planning.| ||||Quarterly I&Ereforecasts and 12month forward| ||||rolling
cash
flow
updated
monthly.
Active| ||||exploration
of opportunities
for cost
sharing| ||||with
other hospices.
Continue
to engage
with| ||||ICB around
commissioning
and funding ofend| ||||oflife care.| |Staffing capacity and||resilience.|Active workforce planning
to anticipate
future| ||||need and develop career pathways.
Major focus| ||||on employee
and volunteer
wellbeing
support.| ||||Continuing
to recruit new volunteers.| ||||Improvements
to ITsystem to allow more| ||||efficient working.
Diversity
audit leading to| ||||actions to broaden recruitment
reach. Closer| ||||working
with StMichael's Hospice to create| ||||shared roles and conditions.| |Safeguarding.|||Safeguarding
Steering Group meets quarterly
to| ||||oversee work.
Corporate safeguarding
risk| ||||register in place and featured in every| ||||departmental
register. Mandatory
training
in| ||||children
and adult safeguarding
for clinical and| ||||non-clinical
staff and volunteers —over 90%| ||||completion.
Freedom to Speak Up Advocates
in| ||||place.| |Major incident/business||continuity.|Major incident and recovery plan updated| ||||annually,
with test exercises undertaken.
IT| ||||system upgraded
to facilitate mobile working.| ||||Daily backups ofkey databases. Flu and Covid| ||||jabs offered to all staff. Focus on infection| ||||control. Regular fire drills and fire risk| ||||assessment.| ## |Cost ofrepairing|Cost ofrepairing|or replacing fixed assets.|Fixed asset register in place. 15year asset| |---|---|---|---| ||||management
plan created and asset| ||||management
reserve being built. Dilapidations| ||||provision
made for shops. Fundraising
for| ||||capital works.| |Fraud, theft|and|cyber crime.|Cyber Essentials Plus accreditation
achieved.| ||||New IThardware
protected by Trend business| ||||security and data encrypted
in the event ofloss.| ||||Servers patched regularly
to provide updated| ||||protection
against ransomware.
Electronic| ||||payments
double signed by the leadership
team.| ||||Annual cyber awareness
mandatory
training.| |Information|governance.||Finance and ITDirector is Senior Information| ||||Risk Officer (SIRO).Data Protection Steering| ||||Group comprising
Information
Asset Owners| ||||meets monthly.
Cyber Essentials Plus| ||||accreditation.
Privacy Impact Assessments
for| ||||each new contract/initiative.
Annual
refresher| ||||trainin .Sentinel AINM s stem facilitates| ||||reporting
and monitoring
ofdata breaches.| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||||||||Meetings|attended| |---|---|---|---|---|---|---|---|---| |Mr S O' Leary|Chair ofTrustees|||||||| |Mr D Adams
¹||||||||| |Dr M Barnes +||||||||| |Mrs JButler ~ 4|Chair ofthe Clinical Governance|||Committee|and Trustee Safeguarding|Lead||| |Ms LChambers|t~|||||||| |Ms BHobson 4
Mr D Holdsworth
Ms FMacIntyre
Mr G Meyer "
¹|t¹Chair ofthe Audit Committee
4 "Chair ofthe People Committee|||||||| |Ms M Richardson|t|||||||| |Mr D Turner t
¹|Chair ofthe Income Generation||Committee|||||| |Members ofTrustee||Committees:||||||| |0Audit Committee||||||||| |4 Clinical Governance||Committee||||||| |¹ Income Generation||Committee||||||| |A People Committee||||||||| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |||||Unrestricted|Restricted|Total|Total| |---|---|---|---|---|---|---|---| |||||Funds|Funds|2023|2022| ||||Notes||||| |INCOME FROM:|||||||| |Donations
and Legacies
Charitable
Activities|||2|5,399,070|255,083|5,654,153|4,673,778| |Statutory Funding
and
Other trading
activities|Grants||2|2,229,382||2,229,382|2,666,649| |Income from Trading|||3|1,260,238||1,260,238|1,135,044| |Income from Lottery||||352,349||352,349|362,300| |Investments|||4|138,165||138,165|60,763| |Other|||5|56,334||56,334|21,767| |Total Income||||9,435,538|255,083|9,690,621|8,920,301| |EXPENDITURE ON:|||||||| |Raising Funds|||||||| |Fundraising
Costs
Trading Costs ofGoods||Sold|6|1,229,446|7,853|1,237,299|956,198| |and Other Costs|||3|1,154,486||1,154,486|968,999| |Charitable
activities|||||||| |In Patient||||3,384,537|35,332|3,419,869|3,578,219| |Therapies||||478,704|29,242|507,946|337,767| |Community
Nursing||||2,561,750|58,901|2,620,651|2,107,777| |Patient &Family Support||||381,001|121,524|502,525|355,612| |Total Expenditure||||9,189,924|252,852|9,442,776|8,304,572| |Net income/(expenditure)|||||||| |before net gains/(losses)||on||245,614|2,231|247,845|615,729| |investments|||||||| |Net gains/(losses)
on|||13|(145,827)||(145,827)|253,288| |investments|||||||| |Net income/(expenditure)||||99,787|2,231|102,018|869,017| |Gross transfers between|funds||19|47,708|(47,708)||| |Net movement
in funds||||147,495|(45,477)|102,018|869,017| |Fund balances at 1 April|2022|||19,682,600|94,730|19,777,330|18,908,313| |Fund
balances
at 31 March|||20,21|19,830,095|49,253|19,879,348|19,777,330| |2023|||||||| ||||Hospice|Hospice|Group|| |---|---|---|---|---|---|---| ||||2023|2022|2023|2022| |||Notes||||| |FIXEDASSETS||||||| |Tangible assets||12|9,506,686|9,817,946|9,506,686|9,817,946| |Investments||13|4,493,457|4,334,859|4,493,356|4,334,758| ||||14,000,143|14,152,805|14,000,042|14,152,704| |CURRENT|ASSETS|||||| |Stocks|||5,463|8,805|10,964|12,882| |Debtors||14|2,986,786|3,265,614|2,932,554|3,191,652| |Cash at bank and in hand|||4,434,083|3,912,202|4,498,075|4,005,285| ||||7,426,332|7,186,621|7,441,593|7,209,819| |CREDITORS: amounts||||||| |falling due|within one year|15|(1,549,641)|(1,563,332)|(1,562,287)|(1,585,193)| |NET CURRENT ASSETS|||5,876,691|5,623,289|5,879,306|5,624,626| |CURRENT|LIABILITIES||19,876,834|19,776,094|19,879,348|19,777,330| |NET ASSETS|||19,876,834|19,776,094|19,879,348|19,777,330| |FUNDS:||||||| |Restricted funds||18|49,253|94,730|49,253|94,730| |Unrestricted|funds:|||||| |Designated|funds|19|13,911,275|14,217,535|13,911,275|14,217,535| |Operating
reserve||19|5,916,306|5,463,829|5,918,820|5,465,065| ||||19,876,834|19,776,094|19,879,348|19,777,330| ## ||||||2023|2022| |---|---|---|---|---|---|---| |||||Note||| |Cash flows from operating
activities:||||||| |Net cash provided
by operating
activities||||21|797,487|1,458,545| |Cash flows from investing
activities:||||||| |Dividends,
interest and rents &om investments|||||138,165|60,763| |Proceeds from the sale ofplant and equipment||||||170| |Purchase ofproperty,
plant and equipment|||||(138,437)|(205,975)| |Transfer ofinvestments||||||(724,295)| |Purchase ofinvestments|||||(1,387,600)|(2,500,000)| |Disposal ofinvestments|||||1,075,458|| |Movement
in investment
cash|||||7,717|| |Net cash (used in) investing
activities|||||(304,697)|(3,369,338)| |Change in cash and cash equivalents|in the reporting|period|||(492,790)|(1,910,792)| |Cash and cash equivalents
at the beginning ofthe reporting|||period||4,005,285|5,916,077| ## ## |1.|ACCOUNTING
POLICIES|| |---|---|---| ||The principal
accounting
policies adopted, judgements
and key sources ofjudgement,
estimation
and uncertainty|| ||in the preparation ofthe financial
statements
are as follows:|| |1.1|Statement ofcompliance|| ||The financial
statements
have been prepared
in accordance with Accounting
and Reporting
by Charities:|| ||Statement ofRecommended
Practice applicable
to charities preparing
their accounts in accordance with the|| ||Financial Reporting
Standard applicable
in the UK and Republic ofIreland (FRS 102) - (Charities SORP Second|| ||Edition, effective 1 January 2019),the Financial Reporting
Standard
applicable
in the UK and Republic of|| ||Ireland (FRS 102)and the Companies
Act 2006.|| ||StWilfiid's Hospice (Eastbourne)
meets the definition ofapublic benefit entity under FRS 102.Assets and|| ||liabilities are initially recognised at historical cost or transaction
value unless otherwise
stated in the relevant|| ||accounting
policy note(s).|| |1.2|General information|| ||The charity is aprivate company
limited by guarantee,
incorporated
in England
and Wales (company number:|| ||01594410)and a charity in England and Wales (charity number: 283686).The charity's
registered office is 1|| ||Broadwater Way, Eastbourne,
East Sussex, BN22 9PZ.|| |1.3|Preparation
ofaccounts on a going concern basis|| ||At the time ofapproving
the financial statements,
Trustees have a reasonable
expectation
that the charity has|| ||adequate
resources to continue
in operational
existence for the foreseeable
future. In addition,
through
'|| ||repriate~sideratiotre&risks~part-of-its-
ceases-and-mitigating-actions-bo|| ||already taken and available
to be taken, the Trustees consider there are no material uncertainties
about the|| ||Charity's
ability to continue as agoing concern.
The review ofthe Charity's
financial position, reserves levels|| ||and future plans gives Trustees confidence the Charity remains agoing concern for the foreseeable
future.|| |1.4|Group financial statements|| ||The financial statements
consolidate
the results ofthe charity and its wholly owned subsidiary
StWil&id's|| ||Hospice Eastbourne
Trading Company
Limited (registered number: 02198239).The results ofthe wholly owned|| ||subsidiary,
StWilfrid's Hospice (Eastboume) Projects Limited, has not been consolidated
into these financial|| ||statements
as its results are immaterial
to the charity and group. A separate Statement ofFinancial Activities|and| ||Income and Expenditure
Account for the charity has not been presented because the charity has taken advantage|| ||ofthe exemption
afforded by section 408ofthe Companies Act 2006.The registered office for these subsidiaries|| ||is the same as the parent.|| ||The consolidated statement offinancial activities, income and expenditure
account and balance sheet include|the| ||financial statements ofthe company
and its subsidiary
undertaking
made up to31March 2023.The company|| ||has taken advantage
ofthe exemption
from presenting
its own income and expenditure
account. The|| ||surplus ofthe company for the financial year amounted
to f68,502 (Surplus 2022:f863,385).All|| ||intercompany
transactions
are eliminated
on consolidation.|| ## ## ## ## ## ||ACCOUNTING
POLICIES (continued)|| |---|---|---| |1.9|Financial instruments|| ||The charity only has financial assets and financial liabilities ofakind that qualify as basic financial|instruments.| ||Basic financial
instruments
are initially recognised at transaction
value and subsequently
measured|at their| ||settlement
value with the exception ofbank loans which are subsequently
measured
at amortised cost using the|| ||effective interest method.|| |1.10|Investments|| ||Investments
are aform ofbasic financial
instruments
and are initially
shown in the financial
statements|at market| ||value. Movements
in the market values ofinvestments
are shown as unrealised
gains and losses in the|Statement of| ||Financial Activities.|| ||Profits and losses on the realisation ofinvestments
are shown as realised gains and losses in the Statement of|| ||Financial Activities. Realised gains and losses on investments
are calculated between sales proceeds and their|| ||opening carrying values or their purchase
value ifacquired subsequent
to the first day ofthe financial|year.| ||Unrealised
gains and losses are calculated as the difference between the fair value at the year end and|their carrying| ||value. Realised and unrealised
investment
gains and losses are combined
in the Statement ofFinancial|Activities.| ||Stock|| ||Stock consists ofpurchased
goods for resale. Stocks are valued at the lower ofcost and net realisable value.|| ||Items donated for resale or distribution
are not included
in the financial statements
until they are sold or|| ||distributed.|| |1.12|Creditors
and provisions|| ||Creditors
and provisions
are recognised
where the charity has a present obligation
resulting
from a|past event that| ||will probably
result in the transfer offunds to athird party and the amount due to settle the obligation
can be|| ||measured
or estimated
reliably. Creditors and provisions
are normally
recognised at their settlement|amount after| ||allowing for any trade discounts
due.|| |1.13|Debtors|| ||Trade and other debtors are recognised at the settlement
amount
due after any trade discount offered.|| ||Prepayments
are valued at the amount prepaid net ofany trade discounts
due.|| |1.14|Cash at bank and in hand|| ||Cash at bank and cash in hand includes cash and short term highly
liquid investments
with a short maturity of|| ||three months or less from the date ofacquisition
or opening ofthe deposit or similar account.|| |1.15|Pensions|| ||The charity operates a defined contribution
pension scheme. Contributions
are charged in the accounts as they|| ||become payable in accordance with the rules ofthe scheme.|| |1.16|Donated goods|| ||The Trustees consider the valuation ofdonated goods for resale at the point ofreceipt is impractical,|due to the| ||high volume oflow value items and the administrative
costs involved
in valuation.
Goods donated for resale are|| ||therefore recognised
in the accounts at the point ofsale.|| |1.17|Fund accounting|| ||General funds are unrestricted
funds which are available for use at the discretion ofthe trustees
in furtherance of|| ||the general objectives ofthe charity and which have not been designated
for other purposes.|| ||Designated
funds comprise unrestricted
funds that have been set aside by the trustees for particular|purposes. The| ||aim and use ofeach designated
fund is set out in the notes to the financial statements.|| ||Restricted funds comprise funds received for aspecific expenditure
as specified by the donor. The aim and use of|| ||each restricted fund is set out in the notes to the financial statements.|| ## ## ## ## |DONATIONS, LEGACIES AND|Unrestricted|Restricted|| |---|---|---|---| |STATUTORY FUNDING|Funds|Funds|2023| |Donations
and Gifts|1,550,470|255,083|1,805,553| |Legacies Receivable|3,848,600||3,848,600| ||399+2||/54~| |Grants Receivable for Core Activities|2,229,382||2,229,382| ||7,628,452|255,083|7,883,535| |DONATIONS, LEGACIES AND|Unrestricted|Restricted|| |STATUTORY FUNDING|Funds|Funds|2022| |Prior Year —2022|||| |Donations
and Gifts|1,326,496|453,563|1,780,059| |Legacies Receivable|2,893,719||2,893,719| ||4,220,215|453,563|4,673,778| |Grants Receivable for Core Activities|2,212,651|453,998|2,666,649| ||6,432,866|907,561|7,340,427| ## ## |ACTIVITIES FOR GENERATING FUNDS||2023||2022|| |---|---|---|---|---|---| |Trading income and costs|||||| |Trading income|||||| |Donated goods income|1,048,977|||955,404|| |Bought in goods income|43,682|||37,951|| |Street cafe income|167,579|||73,273|| |Other operating
income||||68,416|| ||||1,260,238||1,135,044| |Trading expenses|||||| |Cost ofsales|35,877|||29,734|| |Street cafe costs|155,462|||96,774|| |Staffexpenses|475,443|||414,547|| |Property expenses|351,518|||331,284|| |Administration
expenses|135,815|||73,295|| |Dilapidations/Depreciation|371|||23,365|| ||||1,154,486||968,999| |Less interest received|(170)|||(4)|| ||||1,154,316||968,995| |Total (deficit)/surplus|||105,922||166,049| |Number ofshops|||||| ## |4.|INVESTMENT INCOME -|INVESTMENT INCOME -|UNRESTRICTED|||2023|2022| |---|---|---|---|---|---|---|---| ||Rental income from|investment|properties|||25,328|26,746| ||Income from listed investments|||||80,669|21,454| ||Interest receivable|||||32,168|12,563| |||||||138,165|60,763| |5.|OTHER INCOME|—UNRESTRICTED||||2023|2022| ||Other Income|||||56,334|21,767| |||||||56,334|21,767| |6.|TOTAL EXPENDITURE|||Other|Support||| ||||Staff|Direct|Costs|Total|| ||||Costs|Costs|Allocation|2023|| ||Charitable
expenditure||||||| ||Primary
costs||||||| ||Inpatient||2,031,113|156,330|1,232,426|3,419,869|| ||erapies|||||7|| ||Community
Nursing||1,534,596|44,568|1,041,487|2,620,651|| ||Patient k Family Support||303,296|8,290|190,939|502,525|| ||||4,180,873|231,685|2,638,433|7,050,991|| ||Costs ofgenerating|funds|||||| ||Non-charitable
Trading||475,443|679,043||1,154,486|| ||Fundraising||497,734|409,761|329,804|1,237,299|| ||||5,154,050|1,320,487|2,968,237|9,442,776|| ||SUPPORT COSTS|||||2023|| |||||||Total|| ||Support staff|||||1,496,008|| ||Office|||||208,669|| ||Premises and utilities|||||1,237,405|| ||Governance|||||26,155|| |||||||2,968,237|| ||GOVERNANCE COSTS||||||| ||Legal and professional|||||6,940|| ||Auditors'
remuneration|||||19,215|| |||||||26,155|| ## |Prior Year|- 2022|- 2022|||||| |---|---|---|---|---|---|---|---| |||||Staff|Other|Support|Total| ||||||Direct|Costs|| |||||Costs|Costs|Allocation|2022| |Charitable|expenditure||||||| |Primary
costs|||||||| |In Patient||||2,047,604|783,666|746,949|3,578,219| |Therapies||||165,371|67,192|105,204|337,767| |Community|Nursing|||1,280,845|206,227|620,705|2,107,777| |Patient &Family Support||||196,899|85,069|73,644|355,612| |||||3,690,719|1,142,156|1,546,502|6,379,375| |Costs ofgenerating|||funds||||| |Non-charitable||trading||406,005|562,994||968,999| |Fundraising||||504,306|315,127|136,765|956,198| |||||4,601,030|2,020,277|1,683,267|8,304,572| ## |SUPPO|RT COS|TS|2022| |---|---|---|---| ||||Total| |Support|staff||1,252,472| |Office|||120,805| |Premises|and utilities||283,472| |Governance|||26,518| ||||1,683,267| |GOVERNANCE||COSTS|| |Legal and professional|||9,343| |Auditors'|remuneration||17,175| ||||26,518| ## |NET INCOME/(EXPENDITURE)|2023|2022| |---|---|---| |Net income is stated after:||| |Auditors'
remuneration||| |Audit services|17,015|15,125| |Non-audit
services|2,200|2,050| |Depreciation|429,359|421,891| ## |||||||Hospice and Group|Hospice and Group| |---|---|---|---|---|---|---|---| |EMPLOYEES||||||2023|2022| |||||||Number|Number| |The average|monthly|number ofemployees||during the year was:|||| |Therapies||||||10|7| |Community|Nursing|||||60|59| |Patient &Family Support||||||11|10| |Support staff||||||49|54| |Fundraising||||||19|13| |Retail||||||21|24| |||||||241|238| |The full-time|equivalent||number ofemployees||at March was:||| |Inpatient||||||38|43| |Therapies||||||8|7| |Community|Nursing|||||38|30| |Patient &Family Support||||||7|5| |Support staff||||||36|40| |Fundraising||||||15|11| |Retail||||||17|19| |||||||159|155| |Employment|costs||||||| |Wages and salaries||||||5,685,319|5,002,980| |National
insurance||||||496,698|423,807| |Pension costs||||||452,264|426,715| |Redundancy|costs|||||15,777|| |||||||6,650,058|5,853,502| ## ## |2023|2022| |---|---| |Number|Number| ## ## ## |TANGIBLE FIXED|ASSETS|||||| |---|---|---|---|---|---|---| |||||Fixtures||| |Hospice|Land and|Computer|Plant and|And|Motor|| ||Buildings|Equipment|equipment|Fittings|Vehicles|Total| |Cost||||||| |At 1 April 2022|11,061,021|514,537|153,128|729,003|86,904|12,544,593| |Additions||24,236|2,851|111,351||138,438| |Disposals||(16,564)|(15,544)|(238,853)||(270,961)| |At 31March 2023|11,061,021|522,209|140,435|601,501|86,904|12,412,070| |Depreciation||||||| |At 1 April 2022|1,720,738|328,634|96,445|529,364|51,465|2,726,645| |Charge for the year|202,120|111,400|26,044|77,190|12,605|429,359| |On disposals||(15,360)|(14,502)|(220,759)||(250,621)| |At 31March 2023|1,922,858|424,674|107,987|385,795|64,070|2,905,384| |Net BookValue||||||| |At 31March 2023|9,138,163|97,535|32,448|215,706|22,834|9,506,686| |At 31March 2022|9,340,283|185,903|56,683|199,639|35,439|9,817,947| |Group||||||| |Cost||||||| |At 1 April 2022|11,061,021|516,187|153,128|729,003|86,904|12,546,243| |Additions||24,236|2,851|111,351||138,438| |Disposals||(16,564)|(15,544)|(238,853)||(270,961)| |At 31March 2023|11,061,021|523,859|140,435|601,501|86,904|12,413,720| |Depreciation||||||| |At 1 April 2022|1,720,738|330,284|96,445|529,364|51,465|2,728,296| |Charge for the year|202,120|111,400|26,044|77,190|12,605|429,359| |On disposals||(15,360)|(14,502)|(220,759)||(250,621)| |At 31March 2023|1,922,858|426,324|107,987|385,795|64,070|2,907,034| |Net BookValue||||||| |At 31March 2023|9,138,163|97,535|32,448|215,706|22,834|9,506,686| |At 31March 2022|9,340,283|185,903|56,683|199,639|35,439|9,817,947| ## |13|FIXEDASSET|FIXEDASSET|INVESTMENTS|INVESTMENTS|- GROUP AND|- GROUP AND|||| |---|---|---|---|---|---|---|---|---|---| ||HOSPICE||||||Investment|Listed|Total| ||||||||Properties|Investments|Investments| ||Market value|at 1 April 2022|||||935,000|3,399,758|4,334,758| ||Additions
at market value|||||||1,387,600|1,387,600| ||Disposals at cost|||||||(1,075,458)|(1,075,458)| ||Revaluation||||||5,000|(150,827)|(145,827)| ||Movement
in|investment||cash||||(7,717)|(7,717)| ||Group
Market||value at 31||||940,000|3,553,356|4,493,356| ||March 2023||||||||| ||Investment
in subsidiaries||||||||| ||Share capital||||||||| ||.StWilfrid's|Hospice (Eastbourne)|||Projects Limited||||1| ||.StWilfrid's|Hospice Eastbourne|||Trading|Company|||100| ||Limited||||||||| ||Hospice Market||value at 31||||||4,493,457| ||March 2023||||||||| ||Historical cost:||||||||| ||At 31March|2023|||||516,851|3,598,296|4,115,147| ||At 31March|2022|||||516,851|3,517,956|4,034,807| |14.|DEBTORS||||||Hospice||Group| |||||||2023|2022|2023|2022| ||Legacies|||||1,483,701|1,514,772|1,483,701|1,514,772| ||Trade debtors|||||889,742|1,027,240|889,742|1,029,038| ||Amounts
owed by group|||undertakings||54,232|81,652||| ||Prepayments|8r.|accrued income|||471,531|640,491|471,531|646,384| ||Other debtors|||||87,579|1,459|87,579|1,459| |||||||2,986,786|3,265,614|2,932,554|3,191,652| ## ## |15.|CREDITORS: amounts|falling due||Hospice||Group|| |---|---|---|---|---|---|---|---| ||within
one year||2023|2022|2023||2022| ||Trade creditors||308,311|318,752|308,311||325,497| ||Taxes and social security|costs|109,360|27,054|109,360||28,025| ||Other creditors||87,280|174,923|97,511||174,923| ||Accruals||53,745|61,395|56,160||75,540| ||Deferred income||990,945|981,208|990,945||981,208| ||||1,549,641|1,563,332|1,562,287||1,585,193| ## ## ## ## |RESTRICTED INCOME 22/23|RESTRICTED INCOME 22/23|Balance at|Movement|in funds|Balance at| |---|---|---|---|---|---| |||1April|||31March| |||2022|Income|Expenditure|2023| |In Patient Unit|||4,630|(3,417)|1,213| |Hospice In the Community||2,090|44,677|(46,283)|484| |Therapies &Living Well Service|||5,800|(5,000)|800| |Patient &Family Support|||80,538|(80,538)|| |Other Restricted Funds||14,757|56,918|(71,675)|| |Anne Beech Bursary Fund|||6,210||6,210| |IPU Capital &Improving|Patient Care Appeal|26,590||(25,934)|656| |Minibus Appeal||11,651||(4,056)|7,595| |Seahorse Project||6,389|28,358|(34,747)|| |Spiritual
Support Appeal||1,692||(1,692)|| |Spring Appeal 2023|||18,620||18,620| |Syringe Driver Appeal|||9,332||9,332| |||||2 218|4 343| |||94,730|255,083|(300,560)|49,253| ## ## |Prior Year Restricted funds|Prior Year Restricted funds|Balance at|Movement|in funds|Balance at| |---|---|---|---|---|---| |||1April|||31March| |||2021|Income|Expenditure|2022| |IPU Capital and Improving|Patient Care Appeal|158,615|51,462|(183,487)|26,590| |Hospice in the Community||34,358|153,876|(186,144)|2,090| |Wellbeing Appeal||36,090|15,730|(20,259)|31,561| |Minibus Appeal||41,177||(29,526)|11,651| |Spiritual Support Fund||4,477||(2,785)|1,692| |Garden Project||13,084|900|(13,984)|| |Big Lottery Volunteers Project||34,060|77,000|(111,060)|| |Other Restricted Funds||16,328|113,777|(115,348)|14,757| |BBCChildren
in Need Seahorse Project||9,429|34,327|(37,367)|6,389| |Community
Bereavement|Project|3,629|6,491|(10,120)|| |COVID-19 Emergency Response Funding|||453,998|(453,998)|| |||351247|907561|1 164078|94730| ## ## ||||Balance at||Movement|in funds||Balance at| |---|---|---|---|---|---|---|---|---| ||||1April|||||31March| ||||2022|Income|Expenditure|Gains/(losses)|Transfers|2023| |Asset Management|Reserve||700,000|||||700,000| |Legacy Equalisation|Reserve||2,560,177|||||2,560,177| |Strategic Development||Reserve|954,412|||||954,412| |Fixed Asset Reserve|||9,817,946||||(311,260)|9,506,686| |Property Revaluation||Reserve|185,000|||5,000||190,000| |Designated
funds|||14,217,535|||5,000|(311,260)|13,911,275| |General funds|||5,465,065|9,435,537|(9,189,924)|(150,827)|358,968|5,918,820| |Total Unrestricted|Funds||19,682,600|9,435,537|(9,189,924)|(145,827)|47,708|19,830,095| |Restricted Funds|||94,730|255,083|(252,852)||(47,708)|49,253| |Total Reserves|||19,777,330|9,690,620|(9,442,776)|(145,827)||19,879,348| ||||Balance at||Movement|in funds||Balance at| ||||1April|||||31March| ||||2021|Income|Expenditure|Gains/(losses)|Transfers|2022| |Asset Management|Reserve||600,000||||100,000|700,000| |Legacy Equalisation|Reserve||2,560,177|||||2,560,177| |Strategic Development||Reserve|975,130||||(20,718)|954,412| |Fixed Asset Reserve|||10,034,033||||(216,087)|9,817,946| |Revaluation
Reserve||||||185,000||185,000| |Designated
funds|||14,169,340|||185,000|(136,805)|14,217,535| |General funds|||4,387,726|8,012,740|(7,140,494)|68,288|136,805|5,465,065| |Total Unrestricted|Funds||18,557,066|8,012,740|(7,140,494)|253,288||19,682,600| ## ## |20.|ANALYSIS OFNKT ASSETSBETWEEN||General|Designated|Restricted|| |---|---|---|---|---|---|---| ||FUNDS||Funds|Funds|Funds|Total| ||Fund balances at 31 March 2023 are represented|by:||||| ||Tangible Fixed Assets|||9,506,686||9,506,686| ||Fixed Asset Investments||4,493,356|||4,493,356| ||Current Assets||2,987,750|4,404,589|49,253|7,441,593| ||Creditors: amounts
falling due within one year||(1,562,287)|||(1,562,287)| ||||5,918,819|13,911,275|49,253|19,879,348| ||ANALYSIS OFNKT ASSETSBETWEEN||General|Designated|Restricted|| ||FUNDS —Prior Year||Funds|Funds|Funds|Total| ||Fund balances at31March 2022 are represented|by:||||| ||Tangible Fixed Assets|||9,817,946||9,817,946| ||Fixed Asset Investments||4,334,758|||4,334,758| ||Current Assets||2,715,500|4,399,589|94,730|7,209,819| ||Creditors: amounts
falling due within one year||(1,585,193)|||(1,585,193)| ||||5,465,065|14,217,535|94,730|19,777,330| ## |21.|RECONCILIATION
OFNET|INCOME TO|2023|2022| |---|---|---|---|---| ||NET CASH FLOW FROM OPERATING ACTIVITIES|||| ||Net income for the reporting
period (as per the|||| ||statement offinancial activities)||102,018|869,017| ||Adjustments
for:|||| ||Depreciation
charges||429,359|421,891| ||Loss on Disposal ofFixed Assets||20,340|| ||Losses/(Gains)
on investments||145,827|(253,288)| ||Dividends,
interest and rent irom|investments|(138,165)|(60,763)| ||(Profit)/loss
on the sale offixed assets|||(170)| ||Decrease/(increase)
in stocks||1,918|2,781| ||Decrease/(increase)
in debtors||259,098|530,592| ||Increase/(decrease)
in creditors||(22,908)|8,486| ||Changes
in assets held for resale|||| ||Net cash provided
by operating|activities|797,487|1,458,545| |22.|OPERATING LEASESCOMMITMENTS|2023|2022| |---|---|---|---| ||Group Leases:||| ||Within one year|14,026|5,169| ||Within two to five years|40,629|| |||54,655|5,169| ||Charity Leases:||| ||Within one year|14,026|5,169| ||Within two to five years|40,629|| |||54,655|5,169| ## ## ## |||Unrestricted|Restricted|Total|Total| |---|---|---|---|---|---| |||Funds|Funds|2022|2021| |INCOME FROM:|||||| |Donations
and legacies||4,220,215|453,563|4,673,778|5,543,781| |Charitable
activities|||||| |Statutory
funding
and grants||2,212,651|453,998|2,666,649|4,197,697| |Other trading activities|||||| |Income from trading||1,135,044||1,135,044|475,161| |Income from lottery||362,300||362,300|320,003| |Investments||60,763||60,763|34,221| |Other||21,767||21,767|138,108| |Total income||8,012,740|907,561|8,920,301|10,712,323| |EXPENDITURE ON:|||||| |Raising funds|||||| |Fundraising
costs||940,462|15,736|956,198|959,275| |Trading costs ofgoods|sold and||||| |o
er costs||968,999||968,999|877,390| |Charitable
activities|||||| |In Patient||2,854,793|723,426|3,578,219|3,931,650| |Therapies||259,108|78,659|337,767|575,564| |Community
Nursing||1,850,216|257,561|2,107,777|1,717,095| |Patient &Family Support||266,916|88,696|355,612|| |Total expenditure||7,140,494|1,164,078|8,304,572|8,060,974| |Net gains/(losses)
on investments||253,288||253,288|| |Net income/(expenditure)||1,125,534|(256,517)|869,017|2,651,349| |Gross transfers between|funds||||| |Net movement
in funds||1,125,534|(256,517)|869,017|2,651,349| |Fund balances at 1 April|2021|18,557,066|351,247|18,908,313|16,256,964| |Fund balances at31March 2022||19,682,600|94,730|19,777,330|18,908,313|